Sequencing Study Sees Frequent RAS-MAPK Mutations at Neuroblastoma Relapse

In Nature Genetics, an international team led by investigators in the US, Netherlands, and France pinpointed a role for the RAS-MAPK signaling pathway in neuroblastoma relapse.

Read more here: https://www.genomeweb.com/cancer/sequencing-study-sees-frequent-ras-mapk-mutations-neuroblastoma-relapse